PATENT CLAIM ANALYSIS

Application Number: 15964844
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "249000"]

Abstract:
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, U, W 1 , W 2 , W 3 , R 1 -R 6 , and R 9  are described herein.

Claim (Index 43):
A pharmaceutical composition for inhibiting mutant IDH1, comprising a mutant IDH1 inhibitor consisting of the compound of Formula (I-13) in an enatiomeric purity (e.e. %) of at least 98% as determined by chiral HPLC analysis, and a pharmaceutically acceptable carrier:

Metadata:
- Claim Count in Document: 59.0
- Percentile: 91.0
- Lexical Diversity: 1.30233
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14858167', '15964812', '15568051', '14858170', '14858153']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7872964953930912
- 35 USC 102 Novelty (BERT): 0.5318066953953186
- Combined Prediction Score: 0.761747515393314
- Mean Citation Score: 341.3662060000001
- Max Citation Score: 359.19553
- Similarity Product: 229.9051521517092

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test